1
|
Thurman P. Hemostatic Strategies in Trauma. AACN Adv Crit Care 2021; 32:51-63. [PMID: 33725103 DOI: 10.4037/aacnacc2021473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
Bleeding is a leading cause of early death from trauma. Consequently, effective hemostasis can improve the odds of survival after severe traumatic injury. Understanding the pathophysiology of trauma-induced coagulopathy can provide insights into effective strategies to assess and halt hemorrhage. Both physical assessment and appropriate laboratory studies are important in the diagnosis and evaluation of coagulopathy to identify the most effective mechanical and pharmacological strategies to achieve hemostasis. This article uses a case study approach to explore evidence-based techniques to evaluate hemorrhage and strategies to promote hemostasis.
Collapse
Affiliation(s)
- Paul Thurman
- Paul Thurman is Nurse-Scientist, Trauma and Critical Care, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Paca Pratt, 3-S-134, 110 S Paca St, Baltimore, MD 21201
| |
Collapse
|
2
|
Abstract
Hemorrhage is the leading cause of preventable death in combat trauma and the secondary cause of death in civilian trauma. A significant number of deaths due to hemorrhage occur before and in the first hour after hospital arrival. A literature search was performed through PubMed, Scopus, and Institute of Scientific Information databases for English language articles using terms relating to hemostatic agents, prehospital, battlefield or combat dressings, and prehospital hemostatic resuscitation, followed by cross-reference searching. Abstracts were screened to determine relevance and whether appropriate further review of the original articles was warranted. Based on these findings, this paper provides a review of a variety of hemostatic agents ranging from clinically approved products for human use to newly developed concepts with great potential for use in prehospital settings. These hemostatic agents can be administered either systemically or locally to stop bleeding through different mechanisms of action. Comparisons of current hemostatic products and further directions for prehospital hemorrhage control are also discussed.
Collapse
Affiliation(s)
- Henry T Peng
- Defence Research and Development Canada, Toronto Research Centre, 1133 Sheppard Avenue West, Toronto, ON, M3K 2C9, Canada.
| |
Collapse
|
3
|
Rubiano AM, Maldonado M, Montenegro J, Restrepo CM, Khan AA, Monteiro R, Faleiro RM, Carreño JN, Amorim R, Paiva W, Muñoz E, Paranhos J, Soto A, Armonda R, Rosenfeld JV. The Evolving Concept of Damage Control in Neurotrauma: Application of Military Protocols in Civilian Settings with Limited Resources. World Neurosurg 2019; 125:e82-e93. [PMID: 30659971 DOI: 10.1016/j.wneu.2019.01.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2018] [Revised: 01/02/2019] [Accepted: 01/05/2019] [Indexed: 10/27/2022]
Abstract
OBJECTIVE The aim of the present review was to describe the evolution of the damage control concept in neurotrauma, including the surgical technique and medical postoperative care, from the lessons learned from civilian and military neurosurgeons who have applied the concept regularly in practice at military hospitals and civilian institutions in areas with limited resources. METHODS The present narrative review was based on the experience of a group of neurosurgeons who participated in the development of the concept from their practice working in military theaters and low-resources settings with an important burden of blunt and penetrating cranial neurotrauma. RESULTS Damage control surgery in neurotrauma has been described as a sequential therapeutic strategy that supports physiological restoration before anatomical repair in patients with critical injuries. The application of the concept has evolved since the early definitions in 1998. Current strategies have been supported by military neurosurgery experience, and the concept has been applied in civilian settings with limited resources. CONCLUSION Damage control in neurotrauma is a therapeutic option for severe traumatic brain injury management in austere environments. To apply the concept while using an appropriate approach, lessons must be learned from experienced neurosurgeons who use this technique regularly.
Collapse
Affiliation(s)
- Andres M Rubiano
- Institute of Neurosciences and Neurosurgery, El Bosque University, Bogotá, Colombia; NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK; INUB MEDITECH Research Group, MEDITECH Foundation, Cali, Colombia; MEDITECH Foundation, Cali Valle, Colombia.
| | - Miguel Maldonado
- School of Medicine, Central Military Hospital, Nueva Granada Military University, Bogota, Colombia
| | - Jorge Montenegro
- NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK; Department of Research, INUB-MEDITECH Research Group, MEDITECH Foundation, Cali, Colombia; Puerto Asís Hospital, Puerto Asís, Colombia
| | - Claudia M Restrepo
- NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK; Department of Research, INUB-MEDITECH Research Group, MEDITECH Foundation, Cali, Colombia; Central Military Hospital, Nueva Granada Military University, Bogota, Colombia
| | - Ahsan Ali Khan
- NIHR Global Health Research Group on Neurotrauma, University of Cambridge, Cambridge, UK; Department of Research, INUB-MEDITECH Research Group, MEDITECH Foundation, Cali, Colombia; Department of Neurosurgery, Neurotrauma, and Global Surgery, MEDITECH Foundation, Barrow Neurological Institute, University of Cambridge, Cambridge, United Kingdom
| | - Ruy Monteiro
- Neurological Surgery Service, Hospital Municipal Miguel Couto, Río de Janeiro, Brazil
| | - Rodrigo M Faleiro
- Department of Neurosurgery, Hospital Sao Joao XXIII, Belo Horizonte, Minas Gerais, Brazil
| | - José N Carreño
- Neurointensive Care Unit, Santa Fe Foundation University Hospital, Bogotá, Colombia; Central Military Hospital, Nueva Granada Military University, Bogotá, Colombia
| | - Robson Amorim
- Emergency Neurosurgery Service, Hospital das Clínicas, University of São Paulo Medical School, Manaus, Brazil
| | - Wellingson Paiva
- Neurosurgical Intensive Care Unit, Department of Neurology, University of São Paulo, São Paulo, Brazil
| | - Erick Muñoz
- Neurological Surgery Service, Central Military Hospital, Nueva Granada Military University, Bogotá, Colombia
| | - Jorge Paranhos
- Intensive Care Unite and Neuroemergency Service, Santa Casa de Misericordia Hospital, São João del Rei-Minas Gerais, Brazil
| | - Alvaro Soto
- Neurosurgery Service, San Antonio Hospital, Pitalito, Huila, Colombia
| | - Rocco Armonda
- Department of Neuroendovascular Surgery, Med-Star Washington Hospital Center, Med-Star Georgetown University Hospital, Washington, DC, USA
| | - Jeffrey V Rosenfeld
- Department of Neurosurgery, Alfred Hospital, Melbourne, Australia; Department of Surgery, Monash University, Melbourne, Australia; Department of Surgery, F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, Maryland, USA
| |
Collapse
|